JBC Ideal method for primary cell transfection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M908695199 on June 6, 2000

J. Biol. Chem., Vol. 275, Issue 33, 25292-25298, August 18, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/33/25292    most recent
M908695199v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sayer, M. S.
Right arrow Articles by Klinken, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sayer, M. S.
Right arrow Articles by Klinken, S. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Ectopic Expression of Transcription Factor NF-E2 Alters the Phenotype of Erythroid and Monoblastoid Cells*

Melissa S. SayerDagger §, Peta A. TilbrookDagger §, Angelo SpadacciniDagger §, Evan IngleyDagger §, Mohinder K. SarnaDagger §, James H. WilliamsDagger §, Nancy C. Andrews, and S. Peter KlinkenDagger §||

From the Dagger  Laboratory for Cancer Medicine, Western Australian Institute for Medical Research, Royal Perth Hospital, Perth WA 6000, Australia, the § Department of Biochemistry, University of Western Australia, Nedlands 6907, Australia, and the  Howard Hughes Medical Institute, Children's Hospital, and Harvard Medical School, Boston, Massachusetts 02115

In this study, regulation of transcription factor NF-E2 was examined in differentiating erythroid and myeloid cells, and the impact of raising NF-E2 concentrations within these cell types was assessed. NF-E2 was expressed in the J2E erythroid cell line, but the levels increased only marginally during erythropoietin-induced differentiation. In contrast, rare myeloid variants of J2E cells did not express NF-E2. Although NF-E2 was present in M1 monoblastoid cells, it was undetectable as these cells matured into macrophages. Compared with erythroid cells, transcription of the NF-E2 gene was reduced, and the half-life of the mRNA was significantly shorter in monocytoid cells. Ectopic expression of NF-E2 had a profound impact upon the J2E cells; morphologically mature erythroid cells spontaneously emerged in culture, but the cells failed to synthesize hemoglobin, even in the presence of erythropoietin. Although proliferation and viability increased in the NF-E2-transfected J2E cells, their responsiveness to erythropoietin was severely diminished. Strikingly, increasing the expression of NF-E2 in M1 cells produced sublines that contained erythroid or immature megakaryocytic cells. Finally, overexpression of NF-E2 in primary hemopoietic progenitors from fetal liver increased erythroid colony formation in the absence of erythropoietin. These data demonstrate that elevated NF-E2 (i) had a dominant effect on the phenotype and maturation of J2E erythroid cells, (ii) was able to reprogram the M1 monocytoid line, and (iii) promoted the development of erythroid colonies by normal progenitors.


* This work was supported by Grants 99-0596 and 11-0298 from the Natiional Health and Medical Research Council and by grants from the Medical Research Foundation of Royal Perth Hospital and the Cancer Foundation of Western Australia (to P. A. T.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Western Australian Inst. for Medical Research, Level 6, MRF Bldg., Rear 50 Murray St., Perth WA 6000, Australia. Tel.: 61-8-92240334; Fax: 61-8-92240322; E-mail: pklinken@cyllene.uwa.edu.au.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
NEJMHome page
P. J. Campbell and A. R. Green
The Myeloproliferative Disorders
N. Engl. J. Med., December 7, 2006; 355(23): 2452 - 2466.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-P. Lalonde, R. Lim, E. Ingley, P. A. Tilbrook, M. J. Thompson, R. McCulloch, J. G Beaumont, C. Wicking, H. J. Eyre, G. R. Sutherland, et al.
HLS5, a Novel RBCC (Ring Finger, B Box, Coiled-coil) Family Member Isolated from a Hemopoietic Lineage Switch, Is a Candidate Tumor Suppressor
J. Biol. Chem., February 27, 2004; 279(9): 8181 - 8189.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-J. Liu, S.-C. Hou, and C.-K. J. Shen
Erythroid Gene Suppression by NF-{kappa}B
J. Biol. Chem., May 23, 2003; 278(21): 19534 - 19540.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. J. Pratt, A. Drejer, H. Foott, B. Barut, A. Brownlie, J. Postlethwait, Y. Kato, M. Yamamoto, and L. I. Zon
Isolation and characterization of zebrafish NFE2
Physiol Genomics, October 29, 2002; 11(2): 91 - 98.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.